Top 105 probe sets selected for genes underexpressed in DS AMkL compared with non-DS AmkL
Gene . | Fold change . | Gene symbol . | GenBank no. . | Chromosomal location . | Description . |
---|---|---|---|---|---|
211796_s_at | 28.12 | TCRBV13S1-TCRBJ2S1 | AF043179 | — | Homo sapiens T-cell receptor β chain (TCRBV13S1-TCRBJ2S1) mRNA, complete cds |
217022_s_at | 27.97 | MGC27165 | S55735 | 14q32.33 | Hypothetical protein MGC27165 |
204959_at | 19.34 | MNDA | NM_002432 | 1q22 | Myeloid cell nuclear differentiation antigen |
1405_i_at | 17.93 | CCL5 | M21121 | 17q11.2–q12 | Chemokine (C-C motif) ligand 5 |
218847_at | 12.72 | IMP-2 | NM_006548 | 3q28 | IGF-II mRNA-binding protein 2 |
219279_at | 12.58 | — | NM_017718 | 2q36.3 | — |
201743_at | 12.53 | CD14 | NM_000591 | 5q22-q32 | CD14 antigen |
34210_at | 12.48 | CDW52 | N90866 | 1p36 | CDW52 antigen (CAMPATH-1 antigen) |
216035_x_at | 12.48 | TCF7L2 | AV721430 | 10q25.3 | Transcription factor 7-like 2 (T-cell specific, HMG-box) |
211991_s_at | 12.38 | HLA-DPA1 | M27487 | 6p21.3 | Major histocompatibility complex, class II, DP α 1 |
213539_at | 12.18 | CD3D | NM_000732 | 11q23 | CD3D antigen, δ polypeptide (TiT3 complex) |
212651_at | 11.96 | RHOBTB1 | AB018283 | 10q21.3 | Rho-related BTB domain containing 1 |
218223_s_at | 11.36 | CKIP-1 | NM_016274 | 1q21.3 | CK2 interacting protein 1; HQ0024c protein |
200800_s_at | 10.97 | HSPA1A | NM_005345 | 6p21.3 | Heat shock 70-kDa protein 1A |
214677_x_at | 10.96 | IGLJ3 | X57812 | 22q11.1–q11.2 | Immunoglobulin λ joining 3 |
211675_s_at | 10.62 | — | AF054589 | 7q31.2///7q31.2 | — |
210982_s_at | 10.19 | HLA-DRA | M60333 | 6p21.3 | Major histocompatibility complex, class II, DR α |
209138_x_at | 10.17 | — | M87790 | 22q11.1–q11.2 | — |
215379_x_at | 9.819 | IGLJ3 | AV698647 | 22q11.1–q11.2 | Immunoglobulin λ joining 3 |
211368_s_at | 9.609 | CASP1 | U13700 | 11q23 | Caspase-1, apoptosis-related cysteine protease (interleukin 1, β, convertase) |
205081_at | 9.594 | CRIP2 | NM_001311 | 7q11.23 | Cysteine-rich protein 2 |
218559_s_at | 9.557 | MAFB | NM_005461 | 20q11.2–q13.1 | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
211571_s_at | 9.541 | CSPG2 | D32039 | 5q14.3 | Chondroitin sulfate proteoglycan 2 (versican) |
208891_at | 9.516 | DUSP6 | BC003143 | 12q22-q23 | Dual specificity phosphatase 6 |
219229_at | 9.488 | SLCO3A1 | NM_013272 | 15q26 | Solute carrier organic anion transporter family, member 3A1 |
209040_s_at | 9.468 | PSMB8 | U17496 | 6p21.3 | Proteasome (prosome, macropain) subunit, β type, 8 (large multifunctional protease 7) |
215646_s_at | 9.385 | CSPG2 | R94644 | 5q14.3 | Chondroitin sulfate proteoglycan 2 (versican) |
219505_at | 9.344 | CECR1 | NM_017424 | 22q11.2 | Cat eye syndrome chromosome region, candidate 1 |
204891_s_at | 9.093 | LCK | NM_005356 | 1p34.3 | Lymphocyte-specific protein tyrosine kinase |
204661_at | 8.961 | CDW52 | NM_001803 | 1p36 | CDW52 antigen (CAMPATH-1 antigen) |
204619_s_at | 8.71 | CSPG2 | BF590263 | 5q14.3 | Chondroitin sulfate proteoglycan 2 (versican) |
217523_at | 8.62 | — | AV700298 | 11p13 | AV700298 GKC Homo sapiens cDNA clone GKCBVGO5 3′, mRNA sequence |
201506_at | 8.592 | TGFBI | NM_000358 | 5q31 | Transforming growth factor, β-induced, 68 kDa |
208791_at | 8.552 | CLU | M25915 | 8p21-p12 | Clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) |
201641_at | 8.506 | BST2 | NM_004335 | 19p13.2 | Bone marrow stromal cell antigen 2 |
203949_at | 8.477 | MPO | NM_000250 | 17q23.1 | Myeloperoxidase |
204646_at | 8.461 | DPYD | NM_000110 | 1p22 | Dihydropyrimidine dehydrogenase |
218927_s_at | 8.401 | CHST12 | NM_018641 | 7p22 | Carbohydrate (chondroitin 4) sulfotransferase 12 |
208450_at | 8.353 | LGALS2 | NM_006498 | 22q12-q13 | Lectin, galactoside-binding, soluble, 2 (galectin 2) |
221731_x_at | 8.257 | CSPG2 | BF218922 | 5q14.3 | Chondroitin sulfate proteoglycan 2 (versican) |
214500_at | 8.033 | H2AFY | AF044286 | 5q31.3–q32 | H2A histone family, member Y |
208892_s_at | 7.959 | DUSP6 | BC003143 | 12q22-q23 | Dual specificity phosphatase 6 |
209374_s_at | 7.528 | IGHM; MU | BC001872 | 14q32.33 | Synonym: MU; Homo sapiens immunoglobulin heavy constant μ, mRNA (cDNA clone MGC:1228 IMAGE:3544448), complete cds |
211429_s_at | 7.463 | — | AF119873 | — | PRO2275 mRNA, complete cds |
204202_at | 7.244 | KIAA1023 | NM_017604 | 7p22.3 | Homo sapiens KIAA1023 protein (KIAA1023), mRNA |
212063_at | 7.063 | CD44 | BE903880 | 11p13 | CD44 antigen (homing function and Indian blood group system) |
201301_s_at | 7.045 | ANXA4 | BC000182 | 2p13 | Annexin A4 |
209304_x_at | 6.957 | GADD45B | AF087853 | 19p13.3 | Growth arrest and DNA-damage-inducible, β |
210915_x_at | 6.881 | TCRB | M15564 | — | T-cell receptor precursor; human T-cell receptor rearranged βa-chain V-region (V-D-J) mRNA, complete cds |
208894_at | 6.854 | HLA-DRA | M60334 | 6p21.3 | Major histocompatibility complex, class II, DR α |
210473_s_at | 6.844 | — | M37712 | — | Homo sapiens p58/GTA protein kinase mRNA, complete cds |
212068_s_at | 6.822 | KIAA0515 | AB011087 | 9q34.3 | KIAA0515 |
203069_at | 6.8 | SV2A | NM_014849 | 1q21.3 | Synaptic vesicle glycoprotein 2A |
202284_s_at | 6.784 | CDKN1A | NM_000389 | 6p21.2 | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
212592_at | 6.749 | IGJ | AV733266 | 4q21 | Immunoglobulin J polypeptide, linker protein for immunoglobulin α and μ polypeptides |
217762_s_at | 6.711 | RAB31 | BE789881 | 18p11.3 | RAB31, member RAS oncogene family |
203275_at | 6.701 | IRF2 | NM_002199 | 4q34.1–q35.1 | Interferon regulatory factor 2 |
203431_s_at | 6.602 | RICS | NM_014715 | 11q24-q25 | Rho GTPase-activating protein |
203148_s_at | 6.58 | TRIM14 | NM_014788 | 9q31.1 | Tripartite motif-containing 14 |
203408_s_at | 6.548 | SATB1 | NM_002971 | 3p23 | Special AT-rich sequence-binding protein 1 (binds to nuclear matrix/scaffold-associating DNAs) |
Gene . | Fold change . | Gene symbol . | GenBank no. . | Chromosomal location . | Description . |
---|---|---|---|---|---|
211796_s_at | 28.12 | TCRBV13S1-TCRBJ2S1 | AF043179 | — | Homo sapiens T-cell receptor β chain (TCRBV13S1-TCRBJ2S1) mRNA, complete cds |
217022_s_at | 27.97 | MGC27165 | S55735 | 14q32.33 | Hypothetical protein MGC27165 |
204959_at | 19.34 | MNDA | NM_002432 | 1q22 | Myeloid cell nuclear differentiation antigen |
1405_i_at | 17.93 | CCL5 | M21121 | 17q11.2–q12 | Chemokine (C-C motif) ligand 5 |
218847_at | 12.72 | IMP-2 | NM_006548 | 3q28 | IGF-II mRNA-binding protein 2 |
219279_at | 12.58 | — | NM_017718 | 2q36.3 | — |
201743_at | 12.53 | CD14 | NM_000591 | 5q22-q32 | CD14 antigen |
34210_at | 12.48 | CDW52 | N90866 | 1p36 | CDW52 antigen (CAMPATH-1 antigen) |
216035_x_at | 12.48 | TCF7L2 | AV721430 | 10q25.3 | Transcription factor 7-like 2 (T-cell specific, HMG-box) |
211991_s_at | 12.38 | HLA-DPA1 | M27487 | 6p21.3 | Major histocompatibility complex, class II, DP α 1 |
213539_at | 12.18 | CD3D | NM_000732 | 11q23 | CD3D antigen, δ polypeptide (TiT3 complex) |
212651_at | 11.96 | RHOBTB1 | AB018283 | 10q21.3 | Rho-related BTB domain containing 1 |
218223_s_at | 11.36 | CKIP-1 | NM_016274 | 1q21.3 | CK2 interacting protein 1; HQ0024c protein |
200800_s_at | 10.97 | HSPA1A | NM_005345 | 6p21.3 | Heat shock 70-kDa protein 1A |
214677_x_at | 10.96 | IGLJ3 | X57812 | 22q11.1–q11.2 | Immunoglobulin λ joining 3 |
211675_s_at | 10.62 | — | AF054589 | 7q31.2///7q31.2 | — |
210982_s_at | 10.19 | HLA-DRA | M60333 | 6p21.3 | Major histocompatibility complex, class II, DR α |
209138_x_at | 10.17 | — | M87790 | 22q11.1–q11.2 | — |
215379_x_at | 9.819 | IGLJ3 | AV698647 | 22q11.1–q11.2 | Immunoglobulin λ joining 3 |
211368_s_at | 9.609 | CASP1 | U13700 | 11q23 | Caspase-1, apoptosis-related cysteine protease (interleukin 1, β, convertase) |
205081_at | 9.594 | CRIP2 | NM_001311 | 7q11.23 | Cysteine-rich protein 2 |
218559_s_at | 9.557 | MAFB | NM_005461 | 20q11.2–q13.1 | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
211571_s_at | 9.541 | CSPG2 | D32039 | 5q14.3 | Chondroitin sulfate proteoglycan 2 (versican) |
208891_at | 9.516 | DUSP6 | BC003143 | 12q22-q23 | Dual specificity phosphatase 6 |
219229_at | 9.488 | SLCO3A1 | NM_013272 | 15q26 | Solute carrier organic anion transporter family, member 3A1 |
209040_s_at | 9.468 | PSMB8 | U17496 | 6p21.3 | Proteasome (prosome, macropain) subunit, β type, 8 (large multifunctional protease 7) |
215646_s_at | 9.385 | CSPG2 | R94644 | 5q14.3 | Chondroitin sulfate proteoglycan 2 (versican) |
219505_at | 9.344 | CECR1 | NM_017424 | 22q11.2 | Cat eye syndrome chromosome region, candidate 1 |
204891_s_at | 9.093 | LCK | NM_005356 | 1p34.3 | Lymphocyte-specific protein tyrosine kinase |
204661_at | 8.961 | CDW52 | NM_001803 | 1p36 | CDW52 antigen (CAMPATH-1 antigen) |
204619_s_at | 8.71 | CSPG2 | BF590263 | 5q14.3 | Chondroitin sulfate proteoglycan 2 (versican) |
217523_at | 8.62 | — | AV700298 | 11p13 | AV700298 GKC Homo sapiens cDNA clone GKCBVGO5 3′, mRNA sequence |
201506_at | 8.592 | TGFBI | NM_000358 | 5q31 | Transforming growth factor, β-induced, 68 kDa |
208791_at | 8.552 | CLU | M25915 | 8p21-p12 | Clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) |
201641_at | 8.506 | BST2 | NM_004335 | 19p13.2 | Bone marrow stromal cell antigen 2 |
203949_at | 8.477 | MPO | NM_000250 | 17q23.1 | Myeloperoxidase |
204646_at | 8.461 | DPYD | NM_000110 | 1p22 | Dihydropyrimidine dehydrogenase |
218927_s_at | 8.401 | CHST12 | NM_018641 | 7p22 | Carbohydrate (chondroitin 4) sulfotransferase 12 |
208450_at | 8.353 | LGALS2 | NM_006498 | 22q12-q13 | Lectin, galactoside-binding, soluble, 2 (galectin 2) |
221731_x_at | 8.257 | CSPG2 | BF218922 | 5q14.3 | Chondroitin sulfate proteoglycan 2 (versican) |
214500_at | 8.033 | H2AFY | AF044286 | 5q31.3–q32 | H2A histone family, member Y |
208892_s_at | 7.959 | DUSP6 | BC003143 | 12q22-q23 | Dual specificity phosphatase 6 |
209374_s_at | 7.528 | IGHM; MU | BC001872 | 14q32.33 | Synonym: MU; Homo sapiens immunoglobulin heavy constant μ, mRNA (cDNA clone MGC:1228 IMAGE:3544448), complete cds |
211429_s_at | 7.463 | — | AF119873 | — | PRO2275 mRNA, complete cds |
204202_at | 7.244 | KIAA1023 | NM_017604 | 7p22.3 | Homo sapiens KIAA1023 protein (KIAA1023), mRNA |
212063_at | 7.063 | CD44 | BE903880 | 11p13 | CD44 antigen (homing function and Indian blood group system) |
201301_s_at | 7.045 | ANXA4 | BC000182 | 2p13 | Annexin A4 |
209304_x_at | 6.957 | GADD45B | AF087853 | 19p13.3 | Growth arrest and DNA-damage-inducible, β |
210915_x_at | 6.881 | TCRB | M15564 | — | T-cell receptor precursor; human T-cell receptor rearranged βa-chain V-region (V-D-J) mRNA, complete cds |
208894_at | 6.854 | HLA-DRA | M60334 | 6p21.3 | Major histocompatibility complex, class II, DR α |
210473_s_at | 6.844 | — | M37712 | — | Homo sapiens p58/GTA protein kinase mRNA, complete cds |
212068_s_at | 6.822 | KIAA0515 | AB011087 | 9q34.3 | KIAA0515 |
203069_at | 6.8 | SV2A | NM_014849 | 1q21.3 | Synaptic vesicle glycoprotein 2A |
202284_s_at | 6.784 | CDKN1A | NM_000389 | 6p21.2 | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
212592_at | 6.749 | IGJ | AV733266 | 4q21 | Immunoglobulin J polypeptide, linker protein for immunoglobulin α and μ polypeptides |
217762_s_at | 6.711 | RAB31 | BE789881 | 18p11.3 | RAB31, member RAS oncogene family |
203275_at | 6.701 | IRF2 | NM_002199 | 4q34.1–q35.1 | Interferon regulatory factor 2 |
203431_s_at | 6.602 | RICS | NM_014715 | 11q24-q25 | Rho GTPase-activating protein |
203148_s_at | 6.58 | TRIM14 | NM_014788 | 9q31.1 | Tripartite motif-containing 14 |
203408_s_at | 6.548 | SATB1 | NM_002971 | 3p23 | Special AT-rich sequence-binding protein 1 (binds to nuclear matrix/scaffold-associating DNAs) |